Skip to main content
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research logoLink to Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
. 2021 Mar 25;27:e932375-1. doi: 10.12659/MSM.932375

Retracted: Anticancer Action of Psilostachyin-A in 5-Fluorouracil-Resistant Human Liver Carcinoma are Mediated Through Autophagy Induction, G2/M Phase Cell Cycle Arrest and Inhibiting Extracellular-Signal-Regulated Kinase/Mitogen Activated Protein Kinase (ERK/MAPK) Signaling Pathway

Jun Liu 1, Yan Liu 1, Yan Liu 1, Lei Huang 1, Guoliang Wang 1, Jun Wang 1, Xiangang Xu 1, Chengxian Shi 1, Jianzhao Huang 1,
PMCID: PMC8009263  PMID: 33762569

Retraction Notice:

An editorial decision has been made to retract this manuscript due to breach of publishing guidelines, following the identification of non-original and manipulated figures.

Reference

  1. Liu Jun, Liu Yan, Liu Yan, Huang Lei, Wang Guoliang, Wang Jun, Xu Xiangang, Shi Chengxian, Huang Jianzhao. Anticancer Action of Psilostachyin-A in 5-Fluorouracil-Resistant Human Liver Carcinoma are Mediated Through Autophagy Induction, G2/M Phase Cell Cycle Arrest and Inhibiting Extracellular-Signal-Regulated Kinase/Mitogen Activated Protein Kinase (ERK/MAPK) Signaling Pathway. Med Sci Monit. 2019;25:6711–6718. doi: 10.12659/MSM.916635. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Medical Science Monitor : International Medical Journal of Experimental and Clinical Research are provided here courtesy of International Scientific Information, Inc.

RESOURCES